MGO One Seven LLC cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 4.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,568 shares of the company’s stock after selling 208 shares during the quarter. MGO One Seven LLC’s holdings in GE HealthCare Technologies were worth $338,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of GEHC. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at about $25,000. Bogart Wealth LLC increased its stake in shares of GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC increased its stake in shares of GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after acquiring an additional 222 shares during the last quarter. Olde Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at about $35,000. Finally, Game Plan Financial Advisors LLC grew its position in shares of GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after purchasing an additional 375 shares during the period. 82.06% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on GEHC. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research report on Thursday, September 18th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. BTIG Research boosted their price objective on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Finally, Citigroup lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $85.20.
GE HealthCare Technologies Price Performance
Shares of GEHC opened at $74.05 on Monday. The stock has a market capitalization of $33.81 billion, a P/E ratio of 15.17, a P/E/G ratio of 2.83 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a 50 day moving average of $74.51 and a 200-day moving average of $72.03. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the business earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- A Deeper Look at Bid-Ask Spreads
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- How to Invest in Insurance Companies: A GuideĀ
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.